Citations

Mayo Clinic

Showing 10 of 108551 citations.

Faculty Opinions recommendation of Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
Roberts, Lewis R.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | April 14, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717989882.793516785 Get It

Faculty Opinions recommendation of Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.
Roberts, Lewis R.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | April 14, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.725409106.793516783 Get It

Faculty Opinions recommendation of Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features.
Roberts, Lewis R.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | April 14, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.721463410.793516782 Get It

Ischemic Stroke or Systemic Embolism After Transseptal Ablation of Arrhythmias in Patients With Cardiac Implantable Electronic Devices
Madhavan, Malini , Yao, Xiaoxi , Sangaralingham, Lindsey R. , Asirvatham, Samuel J. , Friedman, Paul A. , Sugrue, Alan , Sugrue, Alan M, McLeod, Christopher J. , DeSimone, Christopher V. , Noseworthy, Peter A. , Asirvatham, Samuel J , Yao, Xiaoxi

Journal of the American Heart Association | April 14, 2016 | Volume: 5 | Issue: 4 | Pages: No page available

10.1161/jaha.115.003163 | PMID 27076562 Get It

Background Incidental mobile thrombi are commonly found on endovascular leads of cardiac implantable electronic devices ( CIED s). Transseptal puncture for catheter ablation of arrhythmia poses a risk for paradoxical embolism. We examined risk of ischemic stroke, transient ischemic attack ( TIA ), or systemic embolism after transseptal ablation in patients with and without CIED s. Methods and Results Using a national administrative claims database, 31 720 patients who underwent a transseptal catheter ablation between January 2004 and September 2014 were identified. Two propensity‐matched cohorts were created by matching demographic variables, administrative variables, Charlson Comorbidity Index, CHA 2 DS 2 ‐Vasc score, and year and indication for ablation (5533 and 11 300 patients with and without CIED s). Incidence rates and Cox proportional hazards models were used to estimate risk of ischemic stroke, TIA , or systemic embolism for patients with and without CIED s. Impact of oral anticoagulation ( OAC ) use on the endpoint was examined. Over a mean follow‐up of 2.1 years, the incidence of the combined endpoint was 1.9 per 100 person‐years in patients with CIED s and 1.5 per 100 person‐years in patients without CIED s ( P =0.03). Among patients not on OAC , presence of a cardiac device was associated with an increased risk (hazard ratio [ HR ], 1.71 [1.24–2.35]; P <0.01), whereas there was no association noted among patients treated with OAC ( HR , 0.98 [0.75–1.28]). Conclusion CIED s are associated with an increased risk of stroke, TIA , or systemic embolism after transseptal ablation, but this risk is attenuated with postablation OAC use. Role of anticoagulation post‐transseptal ablation in patients with CIED warrants further investigation.
Target-enrichment sequencing and copy number evaluation in inherited polyneuropathy
Wang, Wei , Dawson, D. Brian, Thorland, Erik C., Lundquist, Patrick A. , Eckloff, Bruce W., Baheti, Saurabh , Evans, Jared M., Scherer, Steven S. , Dyck, P. James B. , Klein, Christopher J. , Wang, Chen , Wu, Yanhong , Klein, Christopher J

Neurology | April 14, 2016 | Volume: 86 | Issue: 19 | Pages: 1762-1771

10.1212/wnl.0000000000002659 | PMID 27164712 Get It

Mental Health, Racial Discrimination, and Tobacco Use Differences Across Rural‐Urban California
Agunwamba, Amenah A. , Williams, David R. , Wilson, Patrick M. , Finney Rutten, Lila J, Kawachi, Ichiro , Rutten, Lila J. Finney , Viswanath, Kasisomayajula

The Journal of Rural Health | April 14, 2016 | Volume: 33 | Issue: 2 | Pages: 180-189

10.1111/jrh.12182 | PMID 27074968 Get It

AbstractObjectiveDisparities in tobacco use persist despite successful policies reducing use within the United States. In particular, the prevalence of tobacco use in rural and certain minority communities is significantly higher compared to that of their counterparts. In this work, we examine the impact of rurality, mental health, and racial discrimination on tobacco use.MethodsData come from the 2003 California Health Interview Survey (n = 42,044). Modified Poisson regression models were adjusted for age, sex, race/ethnicity, birth origin, education, income, insurance, and marital status.ResultsCompared to urban residents, rural residents had a significantly higher risk for smoking after adjustment (RR = 1.10, 95% CI: 1.01‐1.19). Those who reported having experienced racial discrimination also had a significantly greater risk for smoking compared to those who did not (RR = 1.17, 95% CI: 1.07‐1.27). Additionally, those who reported higher stress had a significantly greater risk for smoking (RR = 1.61, 95% CI: 1.07‐1.67). There was evidence of interaction between rurality and race/ethnicity, and rurality and gender (P < .05).ConclusionResiding in rural areas was associated with an increased risk for smoking, above and beyond sociodemographics. There were no significant differences across rural‐urban environments for the relationship between stress and tobacco use—an indication that the impact of stress and discrimination is not buffered or exacerbated by environmental characteristics potentially found in either location. Mechanisms that explain rural‐urban tobacco use disparities need to be explored, and smoking cessation programs and policies should be tailored to target these factors within rural communities.
Balloon dilation causing tracheal rupture: Endoscopic management and literature review
Heyes, Richard , Cervantes, Sergio S., Matthaeus, Jaime, Jaroszewski, Dawn E. , Jaroszewski, Dawn, Lott, David G.

The Laryngoscope | April 14, 2016 | Volume: 126 | Issue: 12 | Pages: 2774-2777

10.1002/lary.25977 | PMID 27075957 Get It

A 72‐year‐old female with a history of idiopathic subglottic tracheal stenosis suffered tracheal rupture during endoscopic balloon dilation. The defect measured 7.5 cm in length, through which the mediastinum was visualized. An 80 × 20‐mm silicone‐covered tracheobronchial stent was deployed over the defect. The patient was extubated subsequent to intraoperative computed tomography demonstrating minimal air escape. Postoperatively, the patient saw no further complications and was discharged 3 days later. The stent was removed 80 days postoperatively revealing healed trachea. Tracheal rupture is a potential risk of balloon dilation, and the list of possible complications is extensive and morbid. Although traditional repair requires an open approach, endoscopic techniques are growing in description, and tracheal stenting was successful in this case. Laryngoscope, 126:2774–2777, 2016
Improving the adoption of thyroid cancer clinical practice guidelines
Likhterov, Ilya , Tuttle, R. Michael , Haser, Grace C. , Su, Henry K. , Bergman, Donald A., Alon, Eran E. , Bernet, Victor , Brett, Elise M., Cobin, Rhoda H., Dewey, Eliza H., Doherty, Gerard M. , Reis, Laura L. Dos, Klopper, Joshua , Lupo, Mark A. , Macháč, Josef, Mechanick, Jeffrey I. , Milas, Mira , Orloff, Lisa A. , Ross, Douglas S. , Rowe, Meghan E. , Smallridge, Robert C., Terris, David J. , Urken, Mark L. , Smallridge, Robert, Lee, Stephanie L. , Mechanick, Jeffrey I. , Randolph, Gregory William , Tufano, Ralph Patrick

The Laryngoscope | April 14, 2016 | Volume: 126 | Issue: 11 | Pages: 2640-2645

10.1002/lary.25986 | PMID 27074952 Get It

Objectives/HypothesisTo present an overview of the barriers to the implementation of clinical practice guidelines (CPGs) in thyroid cancer management and to introduce a computer‐based clinical support system.Data SourcesPubMed.Review Methods: A review of studies on adherence to CPGs was conducted.ResultsAwareness and adoption of CPGs is low in thyroid cancer management. Barriers to implementation include unfamiliarity with the CPGs and financial concerns. Effective interventions to improve adherence are possible, especially when they are readily accessible at the point of care delivery. Computerized clinical support systems show particular promise. The authors introduce the clinical decision making modules (CDMMs) of the Thyroid Cancer Care Collaborative, a thyroid cancer‐specific electronic health record. These computer‐based modules can assist clinicians with implementation of these recommendations in clinical practice.ConclusionComputer‐based support systems can help clinicians understand and adopt the thyroid cancer CPGs. By integrating patient characteristics and guidelines at the point of care delivery, the CDMMs can improve adherence to the guidelines and help clinicians provide high‐quality, evidence‐based, and individualized patient care in the management of differentiated thyroid cancer. Laryngoscope, 126:2640–2645, 2016
Survival following synchronous colon cancer resection
Thiels, Cornelius A. , Naik, Nimesh D. , Bergquist, John R. , Spindler, Blake A., Habermann, Elizabeth B. , Wolff, Bruce G., Mathis, Kellie L. , Kelley, Scott R. , Habermann, Elizabeth , Bergquist, John R , Thiels, Cornelius A

Journal of Surgical Oncology | April 14, 2016 | Volume: 114 | Issue: 1 | Pages: 80-85

10.1002/jso.24258 | PMID 27074754 Get It

BackgroundSynchronous colon cancers, defined as two or more primary colon cancer detected simultaneously at the time of initial diagnosis, account for up to 5% of all colon cancer diagnoses. Management principles and outcomes remain largely undefined.MethodsA retrospective institutional review of patients undergoing curative intent resection for colon adenocarcinoma (Stages I–III) from 1995 to 2007 was performed. Hereditary causes or inflammatory bowel disease were excluded. Matching was performed and Kaplan–Meier analysis was used to compare overall survival.ResultsOf 2,387 patients, 100 (4.2%) had synchronous cancers. Patients with synchronous lesions tended to be older (median 77 vs. 72 years, P < 0.001) with more advanced tumors (41.0% vs. 31.4% Stage III, P = 0.04). After matching, there were no differences in demographics or tumor factors (all P > 0.05). Compared to solitary, synchronous cancers demonstrated an inferior 10‐year overall survival (53.9% vs. 36.5%, P = 0.009). Subset analysis of patients with synchronous cancers showed no difference in overall survival between those with extended versus segmental resections at 120‐months (P = 0.07).ConclusionSynchronous colon cancer is associated with decreased overall survival compared to patients with solitary tumors. Extended resection does not confer a survival benefit in these patients. Further research is needed to determine how to mitigate the poor outcomes. J. Surg. Oncol. 2016;114:80–85. © 2016 Wiley Periodicals, Inc.